To The Moon

As of the close on Friday, $S&P/ASX 200(XJO.AU)$ closed at 8,505.50 on Friday, down 0.49% in the past 5 days.

1. $DEEP YELLOW LTD(DYL.AU)$ +30.89% $BOSS ENERGY LTD(BOE.AU)$ +20.11% and $PALADIN ENERGY LTD(PDN.AU)$+16.83%

Australian uranium shares experienced a significant rally this week, which can be attributed to several factors:

• U.S tech investment in nuclear energy projects has been ramping up, with firms including $Amazon.com(AMZN)$ , and $Meta Platforms, Inc.(META)$ , in recent times announcing projects or commitments in the sector.

• U.S President Trump also signed in an executive order to emphasise nuclear, accelerating interest further.

• Earlier investment in U.S-based X-energy by Amazon had a positive ripple effect on ASX-listed uranium miners.

• The current instability in the Middle East, that had seen oil and gas shares, and spot prices surge into the weekend has also increased the urgency to find alternative sources of energy, should the conflict pressure supply through the all important region.

2. $SANTOS LIMITED(STO.AU)$ +10.63%

• A consortium led by Adnoc’s XRG, with ADQ and Carlyle, has made a non-binding offer to acquire all ordinary shares of Santos at USD 5.76 per share. Investments will focus on Santos' growth in gas, LNG, and low-carbon solutions, enhancing energy security in Australia and the Asia Pacific.

3. $COCHLEAR LTD(COH.AU)$ +8.35

• Cochlear launched the Cochlear Nucleus Nexa System – the world’s first and only smart cochlear implant system.

• UBS upgraded Cochlear from 'neutral' to 'buy' and raised its 12-month price target from $285 to $325, expecting new product releases to drive stronger earnings growth.